HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy
2008 · ChemMedChem · 162 citations
https://doi.org/10.1002/cmdc.200800122
F
Frank Alexis
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
173
Papers
10.5K
Citations
43
h-index
100
i10-index
Frank Alexis is an academic researcher from Universidad San Francisco de Quito. The author has contributed to research in topics: Nanoparticle-Based Drug Delivery & Electrospun Nanofibers in Biomedical Applications & Graphene and Nanomaterials Applications. The author has an h-index of 43, co-authored 148 publications.
ORCID: 0000-0002-0597-7940Papers by this author
worksAdjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
2014 · Vaccine · 160 citations
https://doi.org/10.1016/j.vaccine.2014.02.027
Radioactive polymeric nanoparticles for biomedical application
2020 · Drug Delivery · 55 citations
https://doi.org/10.1080/10717544.2020.1837296
Iodinated Polyesters with Enhanced X-ray Contrast Properties for Biomedical Imaging
2020 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-020-57720-5
Nano-Polypharmacy to Treat Tumors: Coencapsulation of Drug Combinations Using Nanoparticle Technology
2014 · Molecular Therapy · 13 citations
https://doi.org/10.1038/mt.2014.96
Using computer modeling to find new LRRK2 inhibitors for parkinson’s disease
2025 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-025-86926-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat